FIELD: medicine.
SUBSTANCE: diagnosing critical congenital heart disease in newborns with using NT-pro-BNP levels is ensured by measuring N-terminal fragment of a brain natriuretic peptide precursor in blood serum or plasma before the electrocardiographic diagnosis of coronary vessels; if the derived value is more than 5,695 pg/ml, a high risk of critical congenital heart disease is stated.
EFFECT: invention makes it possible to use NT-pro-BNP in the neonatal screening for neonatal critical congenital heart disease.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CHRONIC CARDIAC DECOMPENSATION SEVERITY ASSESSMENT USING QUANTITATIVE CRITERIA FOR CHILDREN WITH INNATE HEART DISEASE | 2010 |
|
RU2438590C2 |
METHOD OF EARLY DETECTION OF PERSISTENT PULMONARY HYPERTENSION AND CRITICAL CONGENITAL HEART DEFECTS IN NEONATES | 2016 |
|
RU2648838C1 |
METHOD OF DIAGNOSING ATRIOVENTRICULAR NODAL ECTOPIC TACHICARDIA IN CHILDREN AFTER SURGICAL TREATMENT OF VALVULAR DEFECTS BY DETECTION OF ATRIOVENTRICULAR DISSOCIATION ON ECG WITH APPLICATION OF MEDICATIONS (ITS VERSIONS) | 2010 |
|
RU2453264C2 |
METHOD OF EVALUATING VERSIONS OF MYOCARDIUM REMODELLING IN NEWBORN BABIES FROM PERINATAL RISK GROUP | 2009 |
|
RU2419094C1 |
METHOD OF PREDICTING OUTCOME OF POST-HYPOXIC DISORDERS OF CARDIO-VASCULAR SYSTEM IN NEWBORNS | 2009 |
|
RU2423072C1 |
METHOD FOR PREDICTION OF HAEMODYNAMICALLY SIGNIFICANT FUNCTIONING ARTERIAL DUCT IN PREMATURE NEWBORNS | 2019 |
|
RU2702990C1 |
METHOD FOR PREDICTION OF DEVELOPING MULTIPLE ORGAN FAILURE IN NEWBORNS IN CRITICAL STATE | 2015 |
|
RU2585143C1 |
WAY OF DIAGNOSTICS OF DEGREE OF DISTURBANCE OF CARDIOVASCULAR SYSTEM FUNCTION AT NEWBORNS FROM GROUP WITH HIGH PERINATAL RISK | 2007 |
|
RU2363000C2 |
DIAGNOSTIC TECHNIQUE FOR PURULENT-SEPTIC COMPLICATIONS IN NEWBORNS | 2011 |
|
RU2484479C1 |
METHOD FOR PREDICTION OF POSTHYPOXIC CARDIOPATHY IN NEWBORNS DELIVERED BY MOTHERS SUFFERING CONGENITAL CARDIAC FAILURES | 2011 |
|
RU2462716C1 |
Authors
Dates
2015-01-10—Published
2013-12-03—Filed